CELESIA, BENEDETTO MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 4.033
AS - Asia 2.230
EU - Europa 1.414
SA - Sud America 429
AF - Africa 291
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.404
Nazione #
US - Stati Uniti d'America 3.919
SG - Singapore 1.180
CN - Cina 625
IT - Italia 475
BR - Brasile 364
IE - Irlanda 260
CI - Costa d'Avorio 191
VN - Vietnam 145
DE - Germania 143
UA - Ucraina 137
RU - Federazione Russa 97
IN - India 93
FI - Finlandia 88
CA - Canada 74
KR - Corea 60
GB - Regno Unito 49
SN - Senegal 41
SE - Svezia 33
NL - Olanda 32
MX - Messico 28
PL - Polonia 25
AR - Argentina 24
HK - Hong Kong 22
NG - Nigeria 20
BD - Bangladesh 18
ZA - Sudafrica 15
BE - Belgio 13
ID - Indonesia 12
CO - Colombia 11
EC - Ecuador 11
IQ - Iraq 11
JP - Giappone 11
AT - Austria 10
ES - Italia 10
FR - Francia 10
BJ - Benin 8
CH - Svizzera 8
TR - Turchia 8
IR - Iran 7
PK - Pakistan 7
PY - Paraguay 6
AU - Australia 5
CZ - Repubblica Ceca 5
GR - Grecia 5
KE - Kenya 5
VE - Venezuela 5
BG - Bulgaria 4
CL - Cile 4
LB - Libano 4
MA - Marocco 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LT - Lituania 2
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
IL - Israele 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MW - Malawi 1
NR - Nauru 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
Totale 8.404
Città #
Dallas 898
Singapore 649
Santa Clara 627
Chandler 378
Dublin 259
Abidjan 191
Los Angeles 171
Ashburn 165
Beijing 161
Chicago 158
Jacksonville 150
Hefei 138
Boardman 115
Catania 102
Munich 89
New York 83
Cambridge 64
Lawrence 64
Seoul 60
Civitanova Marche 57
Andover 55
Ho Chi Minh City 54
Helsinki 50
Kochi 48
Buffalo 46
Dakar 41
Toronto 41
Moscow 39
São Paulo 39
Des Moines 35
Nanjing 34
Hanoi 28
Nanchang 25
Rome 25
Lappeenranta 24
Brooklyn 22
Houston 22
Warsaw 22
Wilmington 22
Hong Kong 21
Abuja 20
The Dalles 20
Columbus 18
Atlanta 17
Denver 17
Milan 16
Amsterdam 15
San Mateo 15
Boston 14
Modica 14
Montreal 14
Palermo 14
Brussels 13
Mexico City 13
Parma 13
Chennai 12
Grafing 12
Philadelphia 12
Phoenix 12
Rende 12
Rio de Janeiro 12
Shenyang 12
Bremen 11
Changsha 11
Dong Ket 11
Jiaxing 11
Milazzo 11
Tremestieri Etneo 11
Hebei 10
Johannesburg 10
Mumbai 10
Orem 10
Ottawa 10
Poplar 10
Tokyo 10
Council Bluffs 9
Saint Petersburg 9
Cotonou 8
London 8
San Francisco 8
Seattle 8
Stockholm 8
Tianjin 8
Turku 8
Redwood City 7
Augusta 6
Bari 6
Brasília 6
Campinas 6
Charlotte 6
Fortaleza 6
New Delhi 6
Porto Alegre 6
Reggio Emilia 6
Curitiba 5
Guarulhos 5
Jinan 5
Manchester 5
Nairobi 5
Norwalk 5
Totale 5.890
Nome #
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 292
A measles outbreak in Catania, Sicily: the importance of high vaccination coverage and early notification of cases for health and economic reasons 124
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study 124
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 117
Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 114
Long-Term Survivors in a Cohort of People Living with HIV Diagnosed between 1985 and 1994: Predictive Factors Associated with More than 25 Years of Survival 113
[In Process Citation] 113
Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis 109
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 104
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 100
Severe Neutropenia after Sarilumab Administration in Two COVID-19 Patients: Case Reports and Literature Review 97
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 95
Baseline CD4/CD8 T-cell Ratio Predicts Prompt Immune Restoration upon cART Initiation 95
HIV Infection Diagnosis in a Late Presenter Patient during a Severe Imported Falciparum Malaria: A Challenging 95
Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report 94
Influence of hepatitis G virus coinfection on the clinical course of chronic hepatitis C 93
Long-term survivors in a cohort of HIV+ patients diagnosed between 1985 and 1992: predictive factors associated with more than 25 years of survival 93
Could we consider the intima-media thickness (c-IMT)> 1 mm as a risk factor for cardiovascular diseases in HIV plus subjects chronically treated with antiretrovirals? 93
HCV and HBV infection among multitransfused thalassemics from eastern Sicily 92
Preliminary investigation on intrafamilial spread of hepatitis C virus (HCV) 92
Hepatic echinococcosis: clinical and therapeutic aspects 90
Efficacy and safety of Atazanavir/Ritonavir therapy in a cohort of treatment-experienced patients 88
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 88
Kidney disease in HIV-infected patients 88
Factors predicting tuberculosis reactivation in HIV-infected patients [PARAMETRI PREDITTIVI DI RIATTIVAZIONE TUBERCOLARE IN SOGGETTI CON INFEZIONE DA HIV] 87
Anxiety disorders and adherence to HAART 85
Trimethoprim-sulfamthoxazole associated severe hypoglicemia: a sulfnylurea like effect 85
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 84
Analysis of impediments to the maintenance in care of people with HIV in Italy 83
Entecavir resistance in a patient with treatment‑naïve HBV: A case report 83
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 83
The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy 82
Rare case of Rhodococcus hoagii bacteremia in an HIV late‑presenter with NTM pulmonary disease: A case report and review of the literature 81
Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature 81
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study 80
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 79
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96-week retrospective study 79
Editorial-Coronavirus disease 2019 and people living with HIV: Clinical considerations 79
Successful extracorporeal membrane oxygenation treatment in an acquired immune deficiency syndrome (AIDS) patient with acute respiratory distress syndrome (ARDS) complicating pneumocystis jirovecii pneumonia: A challenging case 79
Ruolo del rapporto eterosessuale nella trasmissione dell’infezione HIV in un gruppo di tossicodipendenti della Sicilia Orientale. Necessità di modificare le strategie di prevenzione? 78
High-flow nasal cannula oxygenation and tocilizumab administration in patients critically ill with COVID-19: A report of three cases and a literature review 78
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 77
Sifilide ed HIV.Presentazione di tre casi clinici 77
Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review 76
Laryngeal leishmaniasis in a HIV‑positive patient: A case report and review of the literature 75
Pain crisis management in a patient with sickle cell disease during SARS‑CoV‑2 infection: A case report and literature review 75
Predictive criteria of sustained virological response (more than 60 months) to Nevirapine-based antiretroviral treatment 74
Serum tumor necrosis factor in acute and fulminant hepatitis B 74
Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders 74
Possible role of low dose dexamethasone administration in listeria monocytogenes meningoencephalitis: A case series 74
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 73
Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience 73
Microbial translocation in chronic liver diseases 71
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 71
Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment 71
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 71
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 69
Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review 68
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals 68
Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily 67
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 67
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 65
Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV 63
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 63
Localizzazione osteoarticolare multipla in corso di sepsi da Staphylococcus aureus meticillino-resistente: Considerazioni clinico- terapeutiche [Multiple osteo-articular involvement due to methicillin-resistant Staphylococcus aureus septicaemia: clinical and therapeutic evaluation] 63
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 63
HCV and HIV infection among intravenous drug abusers in eastern Sicily 60
Test for CCR5 tropism and treatment with maraviroc in Sicily: an observational retrospective multicentre study 60
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 59
High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: A cross-sectional study 58
Diagnosis, Treatment, and Prevention of HIV Infection among Detainees: A Review of the Literature 57
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 57
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 56
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 56
Prevalenza e distribuzione dell’HHV-8 in differenti popolazioni con e senza infezione da HIV 55
Sexual dysfunction in HIV plus subjects in eastern Sicily 55
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 55
Long-acting drugs: people's expectations and physicians' preparedness. Are we readying to manage it? An Italian survey 54
Serum cytokines as predictors of clinical outcome in AIDS-related intestinal cryptosporidiosis 54
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 54
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 53
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review 53
Prevalence of HLA-B*5701 and access to genetic test in Sicily. A multicenter study 52
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment 52
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 52
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 49
Ageing with HIV: a multidisciplinary review 49
New HIV diagnosis and linkage to care in two outpatient units in South Europe 49
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 48
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort 45
Factors associated with weight gain in people treated with dolutegravir 45
Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report 44
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 42
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 42
Evaluation of HIV transmission cluster among natives and foreigners living Italy 41
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 41
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 40
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 39
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 39
Weight gain: A possible side effect of all antiretrovirals 39
Totale 7.455
Categoria #
all - tutte 31.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.878


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 0 0 0 0 69 14 29 0 35 24 52 18
2021/2022469 39 61 12 5 65 8 72 27 46 11 20 103
2022/20231.035 71 67 14 101 106 171 5 177 245 5 40 33
2023/2024496 28 63 21 32 22 135 5 35 4 22 79 50
2024/20252.656 25 287 110 104 567 334 92 86 236 276 293 246
2025/20263.290 382 380 1.081 530 917 0 0 0 0 0 0 0
Totale 8.626